cITIUS

Citius (CTXR) Announces Results of Mino-Lok Study.

"Mino-Lok has the potential to change the standard of care, which currently calls for a procedure to remove and replace the infected catheter." LIVE QUOTE Citius...
Issam Radd

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

2021 and 2020 Milestones In Plain Sight. Locked and Loaded for most of 2020 - many major milestone events lie around the corner for Citius...

Citius Pharma (CTXR) Video Presentation.

Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment for CoronaVirus and Acute Respiratory Distress. (This is not a vaccine folks, it...

Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.

Interesting Charts From the Day we Discovered it. Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced today that the companies have entered into...
American BriVision

American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.

Is Wall Street Missing American Brivision's Full Clinical Safety and Efficacy Study? We Think it has. Potential Partners are Now Able to Examine Vitargus® the...

There’s Simply No Loyalty Anymore.

TODAY'S LETTER Frontier Bio (FBIO) $3.90. We Have Another Double! American BriVision (ABVC) $4.00. Wait, What? Yet Another Double.Aphex BioCleanse (SNST) $1.80. Wait, What? Seeking...
Roland Rick Perry, Biotech Stock Review, Frontier Bio

And We Have Another Double. Frontier Bio (FBIO) Crosses $4.00.

Sometimes we Can't Beleive Our Luck Over the Last Couple Years. But There You Have it, at Least we Know It's Luck! While we are...

American BriVision’s (ABVC) Novel Polygala Plant Extract, for the Treatment of Clinical Depression.

American BriVision Announces New Patent Filed for Treatment of Major Depressive Disorder. Phase II clinical study completed at Stanford University and five major medical centers...
citius pharma, biotech stock review

Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!

Great headline, right? The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million In reality, we don't know if the...

Latest article

National Investment Bankers Conference

Companies Scheduled to Present Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150...

Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.

This Week's GSA Announcement Marks Sekur’s 4th Major Milestone. GSA Approval is akin to an electrician just starting out in the business, and being told...

Halted Stocks Watch List

We are following Companies which have been suspended by the SEC and will update news related to them here. In near real time. To...